Intas Pharmaceuticals

GPTKB entity

Statements (107)
Predicate Object
gptkbp:instanceOf gptkb:biotechnology
gptkbp:CEO gptkb:Binish_Chudgar
gptkbp:country gptkb:India
gptkbp:focusArea gptkb:allergy
antibiotics
cardiology
immunology
infectious diseases
neurology
oncology
pediatrics
psychiatry
endocrinology
medical devices
orthopedics
personal care products
transplantation
vaccines
women's health
critical care
dermatology
gastroenterology
hepatology
nephrology
ophthalmology
pain management
rheumatology
urology
gynecology
hematology
vitamins
diagnostics
autoimmune diseases
antifungals
antiparasitics
antivirals
corticosteroids
immunosuppressants
supplements
respiratory
men's health
veterinary medicines
antipsychotics
nutraceuticals
anticonvulsants
herbal medicines
hormone replacement therapy
anticoagulants
anti-infectives
antihistamines
antihypertensives
bronchodilators
diabetology
metabolic disorders
animal health products
biologicals
topicals
antidepressants
OTC products
injectables
oral liquids
oral solids
cosmeceuticals
anxiolytics
antidiabetics
antimalarials
antirheumatics
contraceptives
ampoules
suppositories
vials
analgesics
sachets
formulations
antineoplastics
API (Active Pharmaceutical Ingredients)
antigout agents
antimigraine agents
antiparkinsonian agents
antiplatelets
antithyroid agents
cytotoxics
fertility agents
inhalers
lipid-lowering agents
ophthalmics
plasma products
pre-filled syringes
transdermals
gptkbp:foundedIn 1984
gptkbp:founder Hasmukh Chudgar
gptkbp:headquartersLocation gptkb:Ahmedabad
https://www.w3.org/2000/01/rdf-schema#label Intas Pharmaceuticals
gptkbp:industry pharmaceuticals
gptkbp:manufacturingFacilities gptkb:Europe
gptkb:India
gptkb:Mexico
gptkb:UK
gptkbp:market global
gptkbp:numberOfEmployees over 10,000
gptkbp:products biosimilars
generic medicines
gptkbp:revenue over $2 billion (2022)
gptkbp:subsidiary gptkb:Accord_Healthcare
gptkbp:website https://www.intaspharma.com/
gptkbp:bfsParent gptkb:Erythropoietin
gptkbp:bfsLayer 6